BLT 0.00% 2.6¢ benitec biopharma limited

Ann: Chairman's Address to Shareholders, page-46

  1. 1,403 Posts.
    lightbulb Created with Sketch. 96
    Perhaps patient 8 will be part of C/5 seeing C/4 is safe and seemingly not producing much viral response
    They've met all criteria and approval of FDA commitee which they have to be part of being new innovation
    Cant see why not.
    Why delay any further
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.